Verily Life Sciences LLC also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, and as of December 2024, is operating as a standalone company under Alphabet.

On 9 September 2014, the then-Google X division Google Life Sciences acquired Lift Labs, the makers of Liftware.

On August 10, 2015, Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. On December 7, 2015, Google Life Sciences was renamed Verily.

Verily Life Sciences in January 2019 raised $1 billion in funding.

At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson.

In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit.

In August 2021, Verily acquired SignalPath.

In October 2022, the first patient was screened for diabetic retinopathy at the Baton Rouge Clinic using Verily Retinal Service.